NeuroQuant
Best-in-class brain segmentation and volumetric analysis
Software · Cloud SaaSCompany source
Company profile
About CorTechs Labs, Inc
CorTechs Labs, Inc. is a pioneer in AI-powered medical imaging solutions, specializing in quantitative analysis for neurological and oncological conditions. The company merges state-of-the-art medical imaging with clinical data and machine learning to empower physicians in making more accurate and timely diagnostic decisions. Their flagship product, NeuroQuant®, is recognized as the clinical gold standard for MRI brain volume measurement and segmentation, having processed over 2 million brain scans since inception. The NeuroQuant suite includes specialized modules for multiple sclerosis lesion tracking, brain tumor volumetric analysis, PET tracer quantification, and CT alignment. CorTechs also offers OnQ™ Prostate for advanced prostate MRI analysis. The company's solutions are trusted by over 1,500 medical institutions across 44 countries, delivering objective insights that streamline radiology workflows and elevate patient care. With over 18 years of experience in quantitative imaging, CorTechs maintains strategic partnerships with major medical imaging vendors including GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical. Their technology is designed to provide clarity for health professionals while increasing patient confidence in their care through comprehensive, easy-to-interpret reports.
Company description CorTechs Labs, Inc official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Work at CorTechs Labs, Inc?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Alzheimer's disease
- Brain atrophy
- Brain tumors
- Dementia
- Multiple sclerosis
- Neurocognitive disorders
- Neurodegenerative diseases
- Prostate cancer
Who it serves
- Health Systems
- Hospitals
- Imaging Centers
- Radiology Practices
Deployment & integration
Cloud Saas deployment with recorded integration context.
Recorded integration context: Canon Medical, GE Healthcare, Merative, Microsoft, Nuance, Philips Healthcare, Siemens Healthineers.
Geographic context
Markets44 countries globally · Peru · United States
Company sourceOfficial website
Company milestones
Platform expansion
New Category III CPT codes (0865T, 0866T) active as of January 1, 2024 for AI-assisted quantitative brain MRI analysis; TAC Centers Peru celebrating one year of NeuroQuant integration; RSNA 2025 participation
Partnerships
Recorded partners
- Canon Medical
- GE Healthcare
- Getz Healthcare
- Human Longevity
- Imaging Biometrics
- Kryptonite Solutions
- Merative
- Microsoft
- Nuance
- Philips Healthcare
- Siemens Healthineers
- Subtle Medical
- TAC Centers Peru
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
NeuroQuant Brain Tumor
Pre- and post-operative 3D volume analysis of brain tumors
Software · Cloud SaaSCompany source
NeuroQuant CT
Automated CT software for fast, accurate diagnosis
Software · Cloud SaaSCompany source
NeuroQuant Lesion Surveillance
Segmentation and longitudinal tracking of FLAIR, T2*GRE, and SWI lesions
Software · Cloud SaaSCompany source
NeuroQuant MS
Accurately visualize lesions and lesion volume change
Software · Cloud SaaSCompany source
NeuroQuant PET
Rapid, automated subregional tracer quantification
Software · Cloud SaaSCompany source
OnQ Prostate
Next-level prostate MRI for advanced clinical insights
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Discriminant analysis using MRI asymmetry indices and cognitive scores of women with temporal lobe epilepsy or schizophrenia.Neuroradiology · Jul 1, 2024
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
NeuroQuantK241098 · 510k · Aug 22, 2024
OnQ NeuroK210831 · 510k · Nov 19, 2021
NeuroQuantK170981 · 510k · Sep 7, 2017
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Earlier diagnosis of neurodegenerative diseases
Increased diagnostic confidence reported by Fortaleza General Hospital
Quantified localized brain atrophy in minutes
Comparison to large database of normal controls in routine clinical setting
Improved patient care and outcomes
For patients undergoing dementia assessment
TAC Centers Peru
Integration of NeuroQuant suite into clinical practice for advancing neuroimaging innovation
One year of successful NeuroQuant suite integration into clinical practice
Fortaleza General Hospital
Earlier diagnosis of neurodegenerative diseases
Earlier diagnoses of neurodegenerative diseases with increased diagnostic confidence
Scottsdale Medical Imaging
Quantification of localized brain atrophy in routine clinical setting
Radiologists can quantify localized brain atrophy in minutes and compare to large database of normal controls
Virginia Institute of Neuropsychiatry
Clinical gold standard for MRI brain volume measurement
Established as clinical gold standard for MRI brain volume measurement
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from CorTechs Labs, Inc
Recent articles published on CorTechs Labs, Inc's official website.
Read Your Segmentations in the Same Space You Read the Study: Native Space Outputs in NeuroQuant v5.3.0
Read on CorTechs Labs, IncASNR 2026 Highlights the Growing Role of Quantitative Imaging in Neurology
Read on CorTechs Labs, IncSNMMI 2026: Advancing the Future of Quantitative PET in Dementia Imaging
Read on CorTechs Labs, IncThe American Academy of Neurology: Shaping the Future of Neurologic Care
Read on CorTechs Labs, IncHelping Our Clients Share Their Success Stories
Read on CorTechs Labs, Inc07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.